{"entity":{"type":"insider","cik":"0001767037","url":"/insider/0001767037","json_url":"/insider/0001767037.json","name":"Lowdell Mark William","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":6,"first":"2019-09-12","last":"2024-04-24","span_basis":"filed_date"},"name_variants":[{"name":"Lowdell Mark William","source":"filing","n_filings":6,"first_seen":"2019-09-12","last_seen":"2024-04-24"}],"transactions":[{"id":9273018,"accession":"0001213900-24-035721","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-035721","line_url":"/filing/0001213900-24-035721#line-1","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767037","owner_name":"Lowdell Mark William","owner_display_name":"Lowdell Mark William","owner_url":"/insider/0001767037","role":"Officer (Chief Scientific Officer), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14423.0,"shares_display":"14,423","price_per_share":8.32,"price_display":"8.32","price_state":"stated","total_value":119999.36,"total_display":"119,999.36","total_whole":"119,999","shares_owned_after":1510806.0,"shares_owned_after_display":"1,510,806","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-19","filed_date":"2024-04-24","scope":"insider"},{"id":5407501,"accession":"0001213900-21-056740","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-21-056740","line_url":"/filing/0001213900-21-056740#line-1","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767037","owner_name":"Lowdell Mark William","owner_display_name":"Lowdell Mark William","owner_url":"/insider/0001767037","role":"Officer (Chief Scientific Officer), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":701.0,"shares_display":"701","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":14020.0,"total_display":"14,020.00","total_whole":"14,020","shares_owned_after":1472793.0,"shares_owned_after_display":"1,472,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-03","filed_date":"2021-11-04","scope":"insider"},{"id":5174837,"accession":"0001213900-21-055421","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-21-055421","line_url":"/filing/0001213900-21-055421#line-1","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767037","owner_name":"Lowdell Mark William","owner_display_name":"Lowdell Mark William","owner_url":"/insider/0001767037","role":"Officer (Chief Scientific Officer), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2357.0,"shares_display":"2,357","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":47140.0,"total_display":"47,140.00","total_whole":"47,140","shares_owned_after":1473494.0,"shares_owned_after_display":"1,473,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-27","filed_date":"2021-10-29","scope":"insider"},{"id":4905288,"accession":"0001213900-21-054642","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-21-054642","line_url":"/filing/0001213900-21-054642#line-1","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767037","owner_name":"Lowdell Mark William","owner_display_name":"Lowdell Mark William","owner_url":"/insider/0001767037","role":"Officer (Chief Scientific Officer), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":8000.0,"total_display":"8,000.00","total_whole":"8,000","shares_owned_after":1475851.0,"shares_owned_after_display":"1,475,851","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-22","filed_date":"2021-10-26","scope":"insider"},{"id":5301543,"accession":"0001213900-21-036355","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-21-036355","line_url":"/filing/0001213900-21-036355#line-2","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767037","owner_name":"Lowdell Mark William","owner_display_name":"Lowdell Mark William","owner_url":"/insider/0001767037","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24150.0,"shares_display":"24,150","price_per_share":20.19,"price_display":"20.19","price_state":"stated","total_value":487588.5,"total_display":"487,588.50","total_whole":"487,589","shares_owned_after":1476251.0,"shares_owned_after_display":"1,476,251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-08","filed_date":"2021-07-09","scope":"insider"},{"id":5301538,"accession":"0001213900-21-036355","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-21-036355","line_url":"/filing/0001213900-21-036355#line-1","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767037","owner_name":"Lowdell Mark William","owner_display_name":"Lowdell Mark William","owner_url":"/insider/0001767037","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5850.0,"shares_display":"5,850","price_per_share":20.02,"price_display":"20.02","price_state":"stated","total_value":117117.0,"total_display":"117,117.00","total_whole":"117,117","shares_owned_after":1500401.0,"shares_owned_after_display":"1,500,401","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-07","filed_date":"2021-07-09","scope":"insider"},{"id":7981512,"accession":"0001213900-19-017904","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-19-017904","line_url":"/filing/0001213900-19-017904#line-1","is_derivative":false,"issuer_cik":"0001711754","issuer_name":"Inmune Bio, Inc.","issuer_ticker":"INMB","issuer_name_source":null,"issuer_url":"/issuer/0001711754","owner_cik":"0001767037","owner_name":"Lowdell Mark William","owner_display_name":"Lowdell Mark William","owner_url":"/insider/0001767037","role":"Officer (Chief Scientific Officer), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2918.0,"shares_display":"2,918","price_per_share":6.2298,"price_display":"6.23","price_state":"stated","total_value":18178.5564,"total_display":"18,178.56","total_whole":"18,179","shares_owned_after":1506251.0,"shares_owned_after_display":"1,506,251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-11","filed_date":"2019-09-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001711754","name":"Inmune Bio, Inc.","url":"/issuer/0001711754","role":"Officer (Chief Scientific Officer), Ten percent owner","n_filings":6,"first_seen":"2019-09-12","last_seen":"2024-04-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001767037","retrieved_at":"2026-08-24T18:07:54+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}